CLOBAZAM

Generic: CLOBAZAM

Sun Pharmaceutical IndustriesManufacturer
ORALRoute
CLOBAZAMActive Substance
2019-04-15Original Approval

CLOBAZAM is FDA application ANDA210978, sponsored by TARO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
SEIZURE
3,049 reports
2
DRUG INEFFECTIVE
2,709 reports
3
OFF LABEL USE
1,939 reports
4
SOMNOLENCE
1,348 reports
5
DRUG INTERACTION
1,057 reports
6
EPILEPSY
810 reports
7
CONDITION AGGRAVATED
760 reports
8
FATIGUE
739 reports
9
STATUS EPILEPTICUS
624 reports
10
MULTIPLE-DRUG RESISTANCE
584 reports